The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Valacyclovir Market Research Report 2024
Synopsis
Valacyclovir
The global Valacyclovir market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Valacyclovir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Valacyclovir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Valacyclovir include GSK, Mylan Pharmaceuticals, Cobalt Laboratories (Allergan), Sorres Pharma, Sivem Pharmaceuticals, Remedy Repack, Apotex Corporation, Auro Pharma and Biomed Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Valacyclovir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valacyclovir.
Report Scope
The Valacyclovir market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Valacyclovir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Valacyclovir manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Mylan Pharmaceuticals
Cobalt Laboratories (Allergan)
Sorres Pharma
Sivem Pharmaceuticals
Remedy Repack
Apotex Corporation
Auro Pharma
Biomed Pharma
PLIVA
Marcan Pharmaceuticals
Jamp Pharma Corporatio
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Livzon Pharmaceutical Group
Beijing Shuanglu Pharmaceutical
Sichuan Mingxin Pharmaceutical
Sichuan Baili Pharmaceutical
Sichuan Kelun Pharmaceutical
Ansi Pharmaceutical
Yichang Dongyangguang Changjiang Pharmaceutical
Shandong New Era Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Guangdong Baike Pharmaceutical
Chengdu Beite Pharmaceutical
Kunming Yuanrui Pharmaceutical
Yongxin Pharmaceutical Industry
Hubei Huashitong Qianlong Pharmaceutical
Hubei Yikang Pharmaceutical Factory
Hubei Keyi Pharmaceutical
Zhuhai Rundu Pharmaceutical
Marcan Pharmaceuticals
Jamp Pharma Corporatio
Segment by Type
Tablets
Capsule
Granules
Segment by Application
Herpes Zoster Virus
Herpes Simplex Virus
EB Virus
Cytomegalovirus
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Valacyclovir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Valacyclovir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Valacyclovir
The global Valacyclovir market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Valacyclovir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Valacyclovir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Valacyclovir include GSK, Mylan Pharmaceuticals, Cobalt Laboratories (Allergan), Sorres Pharma, Sivem Pharmaceuticals, Remedy Repack, Apotex Corporation, Auro Pharma and Biomed Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Valacyclovir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valacyclovir.
Report Scope
The Valacyclovir market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Valacyclovir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Valacyclovir manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Mylan Pharmaceuticals
Cobalt Laboratories (Allergan)
Sorres Pharma
Sivem Pharmaceuticals
Remedy Repack
Apotex Corporation
Auro Pharma
Biomed Pharma
PLIVA
Marcan Pharmaceuticals
Jamp Pharma Corporatio
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Livzon Pharmaceutical Group
Beijing Shuanglu Pharmaceutical
Sichuan Mingxin Pharmaceutical
Sichuan Baili Pharmaceutical
Sichuan Kelun Pharmaceutical
Ansi Pharmaceutical
Yichang Dongyangguang Changjiang Pharmaceutical
Shandong New Era Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Guangdong Baike Pharmaceutical
Chengdu Beite Pharmaceutical
Kunming Yuanrui Pharmaceutical
Yongxin Pharmaceutical Industry
Hubei Huashitong Qianlong Pharmaceutical
Hubei Yikang Pharmaceutical Factory
Hubei Keyi Pharmaceutical
Zhuhai Rundu Pharmaceutical
Marcan Pharmaceuticals
Jamp Pharma Corporatio
Segment by Type
Tablets
Capsule
Granules
Segment by Application
Herpes Zoster Virus
Herpes Simplex Virus
EB Virus
Cytomegalovirus
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Valacyclovir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Valacyclovir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Valacyclovir Market Overview
1.1 Product Overview and Scope of Valacyclovir
1.2 Valacyclovir Segment by Type
1.2.1 Global Valacyclovir Market Value Comparison by Type (2024-2030)
1.2.2 Tablets
1.2.3 Capsule
1.2.4 Granules
1.3 Valacyclovir Segment by Application
1.3.1 Global Valacyclovir Market Value by Application: (2024-2030)
1.3.2 Herpes Zoster Virus
1.3.3 Herpes Simplex Virus
1.3.4 EB Virus
1.3.5 Cytomegalovirus
1.4 Global Valacyclovir Market Size Estimates and Forecasts
1.4.1 Global Valacyclovir Revenue 2019-2030
1.4.2 Global Valacyclovir Sales 2019-2030
1.4.3 Global Valacyclovir Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Valacyclovir Market Competition by Manufacturers
2.1 Global Valacyclovir Sales Market Share by Manufacturers (2019-2024)
2.2 Global Valacyclovir Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Valacyclovir Average Price by Manufacturers (2019-2024)
2.4 Global Valacyclovir Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Valacyclovir, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Valacyclovir, Product Type & Application
2.7 Valacyclovir Market Competitive Situation and Trends
2.7.1 Valacyclovir Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Valacyclovir Players Market Share by Revenue
2.7.3 Global Valacyclovir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Valacyclovir Retrospective Market Scenario by Region
3.1 Global Valacyclovir Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Valacyclovir Global Valacyclovir Sales by Region: 2019-2030
3.2.1 Global Valacyclovir Sales by Region: 2019-2024
3.2.2 Global Valacyclovir Sales by Region: 2025-2030
3.3 Global Valacyclovir Global Valacyclovir Revenue by Region: 2019-2030
3.3.1 Global Valacyclovir Revenue by Region: 2019-2024
3.3.2 Global Valacyclovir Revenue by Region: 2025-2030
3.4 North America Valacyclovir Market Facts & Figures by Country
3.4.1 North America Valacyclovir Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Valacyclovir Sales by Country (2019-2030)
3.4.3 North America Valacyclovir Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Valacyclovir Market Facts & Figures by Country
3.5.1 Europe Valacyclovir Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Valacyclovir Sales by Country (2019-2030)
3.5.3 Europe Valacyclovir Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Valacyclovir Market Facts & Figures by Country
3.6.1 Asia Pacific Valacyclovir Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Valacyclovir Sales by Country (2019-2030)
3.6.3 Asia Pacific Valacyclovir Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Valacyclovir Market Facts & Figures by Country
3.7.1 Latin America Valacyclovir Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Valacyclovir Sales by Country (2019-2030)
3.7.3 Latin America Valacyclovir Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Valacyclovir Market Facts & Figures by Country
3.8.1 Middle East and Africa Valacyclovir Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Valacyclovir Sales by Country (2019-2030)
3.8.3 Middle East and Africa Valacyclovir Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Valacyclovir Sales by Type (2019-2030)
4.1.1 Global Valacyclovir Sales by Type (2019-2024)
4.1.2 Global Valacyclovir Sales by Type (2025-2030)
4.1.3 Global Valacyclovir Sales Market Share by Type (2019-2030)
4.2 Global Valacyclovir Revenue by Type (2019-2030)
4.2.1 Global Valacyclovir Revenue by Type (2019-2024)
4.2.2 Global Valacyclovir Revenue by Type (2025-2030)
4.2.3 Global Valacyclovir Revenue Market Share by Type (2019-2030)
4.3 Global Valacyclovir Price by Type (2019-2030)
5 Segment by Application
5.1 Global Valacyclovir Sales by Application (2019-2030)
5.1.1 Global Valacyclovir Sales by Application (2019-2024)
5.1.2 Global Valacyclovir Sales by Application (2025-2030)
5.1.3 Global Valacyclovir Sales Market Share by Application (2019-2030)
5.2 Global Valacyclovir Revenue by Application (2019-2030)
5.2.1 Global Valacyclovir Revenue by Application (2019-2024)
5.2.2 Global Valacyclovir Revenue by Application (2025-2030)
5.2.3 Global Valacyclovir Revenue Market Share by Application (2019-2030)
5.3 Global Valacyclovir Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Valacyclovir Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Mylan Pharmaceuticals
6.2.1 Mylan Pharmaceuticals Corporation Information
6.2.2 Mylan Pharmaceuticals Description and Business Overview
6.2.3 Mylan Pharmaceuticals Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mylan Pharmaceuticals Valacyclovir Product Portfolio
6.2.5 Mylan Pharmaceuticals Recent Developments/Updates
6.3 Cobalt Laboratories (Allergan)
6.3.1 Cobalt Laboratories (Allergan) Corporation Information
6.3.2 Cobalt Laboratories (Allergan) Description and Business Overview
6.3.3 Cobalt Laboratories (Allergan) Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cobalt Laboratories (Allergan) Valacyclovir Product Portfolio
6.3.5 Cobalt Laboratories (Allergan) Recent Developments/Updates
6.4 Sorres Pharma
6.4.1 Sorres Pharma Corporation Information
6.4.2 Sorres Pharma Description and Business Overview
6.4.3 Sorres Pharma Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sorres Pharma Valacyclovir Product Portfolio
6.4.5 Sorres Pharma Recent Developments/Updates
6.5 Sivem Pharmaceuticals
6.5.1 Sivem Pharmaceuticals Corporation Information
6.5.2 Sivem Pharmaceuticals Description and Business Overview
6.5.3 Sivem Pharmaceuticals Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sivem Pharmaceuticals Valacyclovir Product Portfolio
6.5.5 Sivem Pharmaceuticals Recent Developments/Updates
6.6 Remedy Repack
6.6.1 Remedy Repack Corporation Information
6.6.2 Remedy Repack Description and Business Overview
6.6.3 Remedy Repack Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Remedy Repack Valacyclovir Product Portfolio
6.6.5 Remedy Repack Recent Developments/Updates
6.7 Apotex Corporation
6.6.1 Apotex Corporation Corporation Information
6.6.2 Apotex Corporation Description and Business Overview
6.6.3 Apotex Corporation Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Apotex Corporation Valacyclovir Product Portfolio
6.7.5 Apotex Corporation Recent Developments/Updates
6.8 Auro Pharma
6.8.1 Auro Pharma Corporation Information
6.8.2 Auro Pharma Description and Business Overview
6.8.3 Auro Pharma Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Auro Pharma Valacyclovir Product Portfolio
6.8.5 Auro Pharma Recent Developments/Updates
6.9 Biomed Pharma
6.9.1 Biomed Pharma Corporation Information
6.9.2 Biomed Pharma Description and Business Overview
6.9.3 Biomed Pharma Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Biomed Pharma Valacyclovir Product Portfolio
6.9.5 Biomed Pharma Recent Developments/Updates
6.10 PLIVA
6.10.1 PLIVA Corporation Information
6.10.2 PLIVA Description and Business Overview
6.10.3 PLIVA Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.10.4 PLIVA Valacyclovir Product Portfolio
6.10.5 PLIVA Recent Developments/Updates
6.11 Marcan Pharmaceuticals
6.11.1 Marcan Pharmaceuticals Corporation Information
6.11.2 Marcan Pharmaceuticals Valacyclovir Description and Business Overview
6.11.3 Marcan Pharmaceuticals Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Marcan Pharmaceuticals Valacyclovir Product Portfolio
6.11.5 Marcan Pharmaceuticals Recent Developments/Updates
6.12 Jamp Pharma Corporatio
6.12.1 Jamp Pharma Corporatio Corporation Information
6.12.2 Jamp Pharma Corporatio Valacyclovir Description and Business Overview
6.12.3 Jamp Pharma Corporatio Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Jamp Pharma Corporatio Valacyclovir Product Portfolio
6.12.5 Jamp Pharma Corporatio Recent Developments/Updates
6.13 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
6.13.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Corporation Information
6.13.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Valacyclovir Description and Business Overview
6.13.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Valacyclovir Product Portfolio
6.13.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Developments/Updates
6.14 Livzon Pharmaceutical Group
6.14.1 Livzon Pharmaceutical Group Corporation Information
6.14.2 Livzon Pharmaceutical Group Valacyclovir Description and Business Overview
6.14.3 Livzon Pharmaceutical Group Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Livzon Pharmaceutical Group Valacyclovir Product Portfolio
6.14.5 Livzon Pharmaceutical Group Recent Developments/Updates
6.15 Beijing Shuanglu Pharmaceutical
6.15.1 Beijing Shuanglu Pharmaceutical Corporation Information
6.15.2 Beijing Shuanglu Pharmaceutical Valacyclovir Description and Business Overview
6.15.3 Beijing Shuanglu Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Beijing Shuanglu Pharmaceutical Valacyclovir Product Portfolio
6.15.5 Beijing Shuanglu Pharmaceutical Recent Developments/Updates
6.16 Sichuan Mingxin Pharmaceutical
6.16.1 Sichuan Mingxin Pharmaceutical Corporation Information
6.16.2 Sichuan Mingxin Pharmaceutical Valacyclovir Description and Business Overview
6.16.3 Sichuan Mingxin Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Sichuan Mingxin Pharmaceutical Valacyclovir Product Portfolio
6.16.5 Sichuan Mingxin Pharmaceutical Recent Developments/Updates
6.17 Sichuan Baili Pharmaceutical
6.17.1 Sichuan Baili Pharmaceutical Corporation Information
6.17.2 Sichuan Baili Pharmaceutical Valacyclovir Description and Business Overview
6.17.3 Sichuan Baili Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Sichuan Baili Pharmaceutical Valacyclovir Product Portfolio
6.17.5 Sichuan Baili Pharmaceutical Recent Developments/Updates
6.18 Sichuan Kelun Pharmaceutical
6.18.1 Sichuan Kelun Pharmaceutical Corporation Information
6.18.2 Sichuan Kelun Pharmaceutical Valacyclovir Description and Business Overview
6.18.3 Sichuan Kelun Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Sichuan Kelun Pharmaceutical Valacyclovir Product Portfolio
6.18.5 Sichuan Kelun Pharmaceutical Recent Developments/Updates
6.19 Ansi Pharmaceutical
6.19.1 Ansi Pharmaceutical Corporation Information
6.19.2 Ansi Pharmaceutical Valacyclovir Description and Business Overview
6.19.3 Ansi Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Ansi Pharmaceutical Valacyclovir Product Portfolio
6.19.5 Ansi Pharmaceutical Recent Developments/Updates
6.20 Yichang Dongyangguang Changjiang Pharmaceutical
6.20.1 Yichang Dongyangguang Changjiang Pharmaceutical Corporation Information
6.20.2 Yichang Dongyangguang Changjiang Pharmaceutical Valacyclovir Description and Business Overview
6.20.3 Yichang Dongyangguang Changjiang Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Yichang Dongyangguang Changjiang Pharmaceutical Valacyclovir Product Portfolio
6.20.5 Yichang Dongyangguang Changjiang Pharmaceutical Recent Developments/Updates
6.21 Shandong New Era Pharmaceutical
6.21.1 Shandong New Era Pharmaceutical Corporation Information
6.21.2 Shandong New Era Pharmaceutical Valacyclovir Description and Business Overview
6.21.3 Shandong New Era Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Shandong New Era Pharmaceutical Valacyclovir Product Portfolio
6.21.5 Shandong New Era Pharmaceutical Recent Developments/Updates
6.22 Shandong Luoxin Pharmaceutical Group
6.22.1 Shandong Luoxin Pharmaceutical Group Corporation Information
6.22.2 Shandong Luoxin Pharmaceutical Group Valacyclovir Description and Business Overview
6.22.3 Shandong Luoxin Pharmaceutical Group Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Shandong Luoxin Pharmaceutical Group Valacyclovir Product Portfolio
6.22.5 Shandong Luoxin Pharmaceutical Group Recent Developments/Updates
6.23 Guangdong Baike Pharmaceutical
6.23.1 Guangdong Baike Pharmaceutical Corporation Information
6.23.2 Guangdong Baike Pharmaceutical Valacyclovir Description and Business Overview
6.23.3 Guangdong Baike Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Guangdong Baike Pharmaceutical Valacyclovir Product Portfolio
6.23.5 Guangdong Baike Pharmaceutical Recent Developments/Updates
6.24 Chengdu Beite Pharmaceutical
6.24.1 Chengdu Beite Pharmaceutical Corporation Information
6.24.2 Chengdu Beite Pharmaceutical Valacyclovir Description and Business Overview
6.24.3 Chengdu Beite Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Chengdu Beite Pharmaceutical Valacyclovir Product Portfolio
6.24.5 Chengdu Beite Pharmaceutical Recent Developments/Updates
6.25 Kunming Yuanrui Pharmaceutical
6.25.1 Kunming Yuanrui Pharmaceutical Corporation Information
6.25.2 Kunming Yuanrui Pharmaceutical Valacyclovir Description and Business Overview
6.25.3 Kunming Yuanrui Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Kunming Yuanrui Pharmaceutical Valacyclovir Product Portfolio
6.25.5 Kunming Yuanrui Pharmaceutical Recent Developments/Updates
6.26 Yongxin Pharmaceutical Industry
6.26.1 Yongxin Pharmaceutical Industry Corporation Information
6.26.2 Yongxin Pharmaceutical Industry Valacyclovir Description and Business Overview
6.26.3 Yongxin Pharmaceutical Industry Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.26.4 Yongxin Pharmaceutical Industry Valacyclovir Product Portfolio
6.26.5 Yongxin Pharmaceutical Industry Recent Developments/Updates
6.27 Hubei Huashitong Qianlong Pharmaceutical
6.27.1 Hubei Huashitong Qianlong Pharmaceutical Corporation Information
6.27.2 Hubei Huashitong Qianlong Pharmaceutical Valacyclovir Description and Business Overview
6.27.3 Hubei Huashitong Qianlong Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.27.4 Hubei Huashitong Qianlong Pharmaceutical Valacyclovir Product Portfolio
6.27.5 Hubei Huashitong Qianlong Pharmaceutical Recent Developments/Updates
6.28 Hubei Yikang Pharmaceutical Factory
6.28.1 Hubei Yikang Pharmaceutical Factory Corporation Information
6.28.2 Hubei Yikang Pharmaceutical Factory Valacyclovir Description and Business Overview
6.28.3 Hubei Yikang Pharmaceutical Factory Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.28.4 Hubei Yikang Pharmaceutical Factory Valacyclovir Product Portfolio
6.28.5 Hubei Yikang Pharmaceutical Factory Recent Developments/Updates
6.29 Hubei Keyi Pharmaceutical
6.29.1 Hubei Keyi Pharmaceutical Corporation Information
6.29.2 Hubei Keyi Pharmaceutical Valacyclovir Description and Business Overview
6.29.3 Hubei Keyi Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.29.4 Hubei Keyi Pharmaceutical Valacyclovir Product Portfolio
6.29.5 Hubei Keyi Pharmaceutical Recent Developments/Updates
6.30 Zhuhai Rundu Pharmaceutical
6.30.1 Zhuhai Rundu Pharmaceutical Corporation Information
6.30.2 Zhuhai Rundu Pharmaceutical Valacyclovir Description and Business Overview
6.30.3 Zhuhai Rundu Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.30.4 Zhuhai Rundu Pharmaceutical Valacyclovir Product Portfolio
6.30.5 Zhuhai Rundu Pharmaceutical Recent Developments/Updates
6.31 Marcan Pharmaceuticals
6.31.1 Marcan Pharmaceuticals Corporation Information
6.31.2 Marcan Pharmaceuticals Valacyclovir Description and Business Overview
6.31.3 Marcan Pharmaceuticals Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.31.4 Marcan Pharmaceuticals Valacyclovir Product Portfolio
6.31.5 Marcan Pharmaceuticals Recent Developments/Updates
6.32 Jamp Pharma Corporatio
6.32.1 Jamp Pharma Corporatio Corporation Information
6.32.2 Jamp Pharma Corporatio Valacyclovir Description and Business Overview
6.32.3 Jamp Pharma Corporatio Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.32.4 Jamp Pharma Corporatio Valacyclovir Product Portfolio
6.32.5 Jamp Pharma Corporatio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Valacyclovir Industry Chain Analysis
7.2 Valacyclovir Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Valacyclovir Production Mode & Process
7.4 Valacyclovir Sales and Marketing
7.4.1 Valacyclovir Sales Channels
7.4.2 Valacyclovir Distributors
7.5 Valacyclovir Customers
8 Valacyclovir Market Dynamics
8.1 Valacyclovir Industry Trends
8.2 Valacyclovir Market Drivers
8.3 Valacyclovir Market Challenges
8.4 Valacyclovir Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Valacyclovir Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Valacyclovir Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Valacyclovir Market Competitive Situation by Manufacturers in 2023
Table 4. Global Valacyclovir Sales (KG) of Key Manufacturers (2019-2024)
Table 5. Global Valacyclovir Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Valacyclovir Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Valacyclovir Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Valacyclovir Average Price (US$/G) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Valacyclovir, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Valacyclovir, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Valacyclovir, Product Type & Application
Table 12. Global Key Manufacturers of Valacyclovir, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Valacyclovir by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valacyclovir as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Valacyclovir Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Valacyclovir Sales by Region (2019-2024) & (KG)
Table 18. Global Valacyclovir Sales Market Share by Region (2019-2024)
Table 19. Global Valacyclovir Sales by Region (2025-2030) & (KG)
Table 20. Global Valacyclovir Sales Market Share by Region (2025-2030)
Table 21. Global Valacyclovir Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Valacyclovir Revenue Market Share by Region (2019-2024)
Table 23. Global Valacyclovir Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Valacyclovir Revenue Market Share by Region (2025-2030)
Table 25. North America Valacyclovir Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Valacyclovir Sales by Country (2019-2024) & (KG)
Table 27. North America Valacyclovir Sales by Country (2025-2030) & (KG)
Table 28. North America Valacyclovir Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Valacyclovir Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Valacyclovir Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Valacyclovir Sales by Country (2019-2024) & (KG)
Table 32. Europe Valacyclovir Sales by Country (2025-2030) & (KG)
Table 33. Europe Valacyclovir Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Valacyclovir Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Valacyclovir Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Valacyclovir Sales by Region (2019-2024) & (KG)
Table 37. Asia Pacific Valacyclovir Sales by Region (2025-2030) & (KG)
Table 38. Asia Pacific Valacyclovir Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Valacyclovir Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Valacyclovir Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Valacyclovir Sales by Country (2019-2024) & (KG)
Table 42. Latin America Valacyclovir Sales by Country (2025-2030) & (KG)
Table 43. Latin America Valacyclovir Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Valacyclovir Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Valacyclovir Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Valacyclovir Sales by Country (2019-2024) & (KG)
Table 47. Middle East & Africa Valacyclovir Sales by Country (2025-2030) & (KG)
Table 48. Middle East & Africa Valacyclovir Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Valacyclovir Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Valacyclovir Sales (KG) by Type (2019-2024)
Table 51. Global Valacyclovir Sales (KG) by Type (2025-2030)
Table 52. Global Valacyclovir Sales Market Share by Type (2019-2024)
Table 53. Global Valacyclovir Sales Market Share by Type (2025-2030)
Table 54. Global Valacyclovir Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Valacyclovir Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Valacyclovir Revenue Market Share by Type (2019-2024)
Table 57. Global Valacyclovir Revenue Market Share by Type (2025-2030)
Table 58. Global Valacyclovir Price (US$/G) by Type (2019-2024)
Table 59. Global Valacyclovir Price (US$/G) by Type (2025-2030)
Table 60. Global Valacyclovir Sales (KG) by Application (2019-2024)
Table 61. Global Valacyclovir Sales (KG) by Application (2025-2030)
Table 62. Global Valacyclovir Sales Market Share by Application (2019-2024)
Table 63. Global Valacyclovir Sales Market Share by Application (2025-2030)
Table 64. Global Valacyclovir Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Valacyclovir Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Valacyclovir Revenue Market Share by Application (2019-2024)
Table 67. Global Valacyclovir Revenue Market Share by Application (2025-2030)
Table 68. Global Valacyclovir Price (US$/G) by Application (2019-2024)
Table 69. Global Valacyclovir Price (US$/G) by Application (2025-2030)
Table 70. GSK Corporation Information
Table 71. GSK Description and Business Overview
Table 72. GSK Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 73. GSK Valacyclovir Product
Table 74. GSK Recent Developments/Updates
Table 75. Mylan Pharmaceuticals Corporation Information
Table 76. Mylan Pharmaceuticals Description and Business Overview
Table 77. Mylan Pharmaceuticals Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 78. Mylan Pharmaceuticals Valacyclovir Product
Table 79. Mylan Pharmaceuticals Recent Developments/Updates
Table 80. Cobalt Laboratories (Allergan) Corporation Information
Table 81. Cobalt Laboratories (Allergan) Description and Business Overview
Table 82. Cobalt Laboratories (Allergan) Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 83. Cobalt Laboratories (Allergan) Valacyclovir Product
Table 84. Cobalt Laboratories (Allergan) Recent Developments/Updates
Table 85. Sorres Pharma Corporation Information
Table 86. Sorres Pharma Description and Business Overview
Table 87. Sorres Pharma Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 88. Sorres Pharma Valacyclovir Product
Table 89. Sorres Pharma Recent Developments/Updates
Table 90. Sivem Pharmaceuticals Corporation Information
Table 91. Sivem Pharmaceuticals Description and Business Overview
Table 92. Sivem Pharmaceuticals Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 93. Sivem Pharmaceuticals Valacyclovir Product
Table 94. Sivem Pharmaceuticals Recent Developments/Updates
Table 95. Remedy Repack Corporation Information
Table 96. Remedy Repack Description and Business Overview
Table 97. Remedy Repack Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 98. Remedy Repack Valacyclovir Product
Table 99. Remedy Repack Recent Developments/Updates
Table 100. Apotex Corporation Corporation Information
Table 101. Apotex Corporation Description and Business Overview
Table 102. Apotex Corporation Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 103. Apotex Corporation Valacyclovir Product
Table 104. Apotex Corporation Recent Developments/Updates
Table 105. Auro Pharma Corporation Information
Table 106. Auro Pharma Description and Business Overview
Table 107. Auro Pharma Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 108. Auro Pharma Valacyclovir Product
Table 109. Auro Pharma Recent Developments/Updates
Table 110. Biomed Pharma Corporation Information
Table 111. Biomed Pharma Description and Business Overview
Table 112. Biomed Pharma Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 113. Biomed Pharma Valacyclovir Product
Table 114. Biomed Pharma Recent Developments/Updates
Table 115. PLIVA Corporation Information
Table 116. PLIVA Description and Business Overview
Table 117. PLIVA Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 118. PLIVA Valacyclovir Product
Table 119. PLIVA Recent Developments/Updates
Table 120. Marcan Pharmaceuticals Corporation Information
Table 121. Marcan Pharmaceuticals Description and Business Overview
Table 122. Marcan Pharmaceuticals Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 123. Marcan Pharmaceuticals Valacyclovir Product
Table 124. Marcan Pharmaceuticals Recent Developments/Updates
Table 125. Jamp Pharma Corporatio Corporation Information
Table 126. Jamp Pharma Corporatio Description and Business Overview
Table 127. Jamp Pharma Corporatio Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 128. Jamp Pharma Corporatio Valacyclovir Product
Table 129. Jamp Pharma Corporatio Recent Developments/Updates
Table 130. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Corporation Information
Table 131. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Description and Business Overview
Table 132. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 133. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Valacyclovir Product
Table 134. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Developments/Updates
Table 135. Livzon Pharmaceutical Group Corporation Information
Table 136. Livzon Pharmaceutical Group Description and Business Overview
Table 137. Livzon Pharmaceutical Group Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 138. Livzon Pharmaceutical Group Valacyclovir Product
Table 139. Livzon Pharmaceutical Group Recent Developments/Updates
Table 140. Beijing Shuanglu Pharmaceutical Corporation Information
Table 141. Beijing Shuanglu Pharmaceutical Description and Business Overview
Table 142. Beijing Shuanglu Pharmaceutical Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 143. Beijing Shuanglu Pharmaceutical Valacyclovir Product
Table 144. Beijing Shuanglu Pharmaceutical Recent Developments/Updates
Table 145. Sichuan Mingxin Pharmaceutical Corporation Information
Table 146. Sichuan Mingxin Pharmaceutical Description and Business Overview
Table 147. Sichuan Mingxin Pharmaceutical Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 148. Sichuan Mingxin Pharmaceutical Valacyclovir Product
Table 149. Sichuan Mingxin Pharmaceutical Recent Developments/Updates
Table 150. Sichuan Baili Pharmaceutical Corporation Information
Table 151. Sichuan Baili Pharmaceutical Description and Business Overview
Table 152. Sichuan Baili Pharmaceutical Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 153. Sichuan Baili Pharmaceutical Valacyclovir Product
Table 154. Sichuan Baili Pharmaceutical Recent Developments/Updates
Table 155. Sichuan Kelun Pharmaceutical Corporation Information
Table 156. Sichuan Kelun Pharmaceutical Description and Business Overview
Table 157. Sichuan Kelun Pharmaceutical Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 158. Sichuan Kelun Pharmaceutical Valacyclovir Product
Table 159. Sichuan Kelun Pharmaceutical Recent Developments/Updates
Table 160. Ansi Pharmaceutical Corporation Information
Table 161. Ansi Pharmaceutical Description and Business Overview
Table 162. Ansi Pharmaceutical Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 163. Ansi Pharmaceutical Valacyclovir Product
Table 164. Ansi Pharmaceutical Recent Developments/Updates
Table 165. Yichang Dongyangguang Changjiang Pharmaceutical Corporation Information
Table 166. Yichang Dongyangguang Changjiang Pharmaceutical Description and Business Overview
Table 167. Yichang Dongyangguang Changjiang Pharmaceutical Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 168. Yichang Dongyangguang Changjiang Pharmaceutical Valacyclovir Product
Table 169. Yichang Dongyangguang Changjiang Pharmaceutical Recent Developments/Updates
Table 170. Shandong New Era Pharmaceutical Corporation Information
Table 171. Shandong New Era Pharmaceutical Description and Business Overview
Table 172. Shandong New Era Pharmaceutical Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 173. Shandong New Era Pharmaceutical Valacyclovir Product
Table 174. Shandong New Era Pharmaceutical Recent Developments/Updates
Table 175. Shandong Luoxin Pharmaceutical Group Corporation Information
Table 176. Shandong Luoxin Pharmaceutical Group Description and Business Overview
Table 177. Shandong Luoxin Pharmaceutical Group Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 178. Shandong Luoxin Pharmaceutical Group Valacyclovir Product
Table 179. Shandong Luoxin Pharmaceutical Group Recent Developments/Updates
Table 180. Guangdong Baike Pharmaceutical Corporation Information
Table 181. Guangdong Baike Pharmaceutical Description and Business Overview
Table 182. Guangdong Baike Pharmaceutical Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 183. Guangdong Baike Pharmaceutical Valacyclovir Product
Table 184. Guangdong Baike Pharmaceutical Recent Developments/Updates
Table 185. Chengdu Beite Pharmaceutical Corporation Information
Table 186. Chengdu Beite Pharmaceutical Description and Business Overview
Table 187. Chengdu Beite Pharmaceutical Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 188. Chengdu Beite Pharmaceutical Valacyclovir Product
Table 189. Chengdu Beite Pharmaceutical Recent Developments/Updates
Table 190. Kunming Yuanrui Pharmaceutical Corporation Information
Table 191. Kunming Yuanrui Pharmaceutical Description and Business Overview
Table 192. Kunming Yuanrui Pharmaceutical Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 193. Kunming Yuanrui Pharmaceutical Valacyclovir Product
Table 194. Kunming Yuanrui Pharmaceutical Recent Developments/Updates
Table 195. Yongxin Pharmaceutical Industry Corporation Information
Table 196. Yongxin Pharmaceutical Industry Description and Business Overview
Table 197. Yongxin Pharmaceutical Industry Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 198. Yongxin Pharmaceutical Industry Valacyclovir Product
Table 199. Yongxin Pharmaceutical Industry Recent Developments/Updates
Table 200. Hubei Huashitong Qianlong Pharmaceutical Corporation Information
Table 201. Hubei Huashitong Qianlong Pharmaceutical Description and Business Overview
Table 202. Hubei Huashitong Qianlong Pharmaceutical Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 203. Hubei Huashitong Qianlong Pharmaceutical Valacyclovir Product
Table 204. Hubei Huashitong Qianlong Pharmaceutical Recent Developments/Updates
Table 205. Hubei Yikang Pharmaceutical Factory Corporation Information
Table 206. Hubei Yikang Pharmaceutical Factory Description and Business Overview
Table 207. Hubei Yikang Pharmaceutical Factory Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 208. Hubei Yikang Pharmaceutical Factory Valacyclovir Product
Table 209. Hubei Yikang Pharmaceutical Factory Recent Developments/Updates
Table 210. Hubei Keyi Pharmaceutical Corporation Information
Table 211. Hubei Keyi Pharmaceutical Description and Business Overview
Table 212. Hubei Keyi Pharmaceutical Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 213. Hubei Keyi Pharmaceutical Valacyclovir Product
Table 214. Hubei Keyi Pharmaceutical Recent Developments/Updates
Table 215. Zhuhai Rundu Pharmaceutical Corporation Information
Table 216. Zhuhai Rundu Pharmaceutical Description and Business Overview
Table 217. Zhuhai Rundu Pharmaceutical Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 218. Zhuhai Rundu Pharmaceutical Valacyclovir Product
Table 219. Zhuhai Rundu Pharmaceutical Recent Developments/Updates
Table 220. Key Raw Materials Lists
Table 221. Raw Materials Key Suppliers Lists
Table 222. Valacyclovir Distributors List
Table 223. Valacyclovir Customers List
Table 224. Valacyclovir Market Trends
Table 225. Valacyclovir Market Drivers
Table 226. Valacyclovir Market Challenges
Table 227. Valacyclovir Market Restraints
Table 228. Research Programs/Design for This Report
Table 229. Key Data Information from Secondary Sources
Table 230. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Valacyclovir
Figure 2. Global Valacyclovir Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Valacyclovir Market Share by Type in 2023 & 2030
Figure 4. Tablets Product Picture
Figure 5. Capsule Product Picture
Figure 6. Granules Product Picture
Figure 7. Global Valacyclovir Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Valacyclovir Market Share by Application in 2023 & 2030
Figure 9. Herpes Zoster Virus
Figure 10. Herpes Simplex Virus
Figure 11. EB Virus
Figure 12. Cytomegalovirus
Figure 13. Global Valacyclovir Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Valacyclovir Market Size (2019-2030) & (US$ Million)
Figure 15. Global Valacyclovir Sales (2019-2030) & (KG)
Figure 16. Global Valacyclovir Average Price (US$/G) & (2019-2030)
Figure 17. Valacyclovir Report Years Considered
Figure 18. Valacyclovir Sales Share by Manufacturers in 2023
Figure 19. Global Valacyclovir Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Valacyclovir Players: Market Share by Revenue in 2023
Figure 21. Valacyclovir Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Valacyclovir Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Valacyclovir Sales Market Share by Country (2019-2030)
Figure 24. North America Valacyclovir Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Valacyclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Valacyclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Valacyclovir Sales Market Share by Country (2019-2030)
Figure 28. Europe Valacyclovir Revenue Market Share by Country (2019-2030)
Figure 29. Germany Valacyclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Valacyclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Valacyclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Valacyclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Valacyclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Valacyclovir Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Valacyclovir Revenue Market Share by Region (2019-2030)
Figure 36. China Valacyclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Valacyclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Valacyclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Valacyclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Valacyclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Valacyclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Valacyclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Valacyclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Valacyclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Valacyclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Valacyclovir Sales Market Share by Country (2019-2030)
Figure 47. Latin America Valacyclovir Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Valacyclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Valacyclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Valacyclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Valacyclovir Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Valacyclovir Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Valacyclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Valacyclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE Valacyclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Valacyclovir by Type (2019-2030)
Figure 57. Global Revenue Market Share of Valacyclovir by Type (2019-2030)
Figure 58. Global Valacyclovir Price (US$/G) by Type (2019-2030)
Figure 59. Global Sales Market Share of Valacyclovir by Application (2019-2030)
Figure 60. Global Revenue Market Share of Valacyclovir by Application (2019-2030)
Figure 61. Global Valacyclovir Price (US$/G) by Application (2019-2030)
Figure 62. Valacyclovir Value Chain
Figure 63. Valacyclovir Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
